⌘K

Login Start Free

Home/Filings/4/0001852075-25-000005

4//SEC Filing

Dar Zavain 4

Accession 0001852075-25-000005

CIK 0001601830other

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:27 PM ET

Size

4.8 KB

Accession

0001852075-25-000005

Insider Transaction Report

Form 4

Period: 2025-10-01

RECURSION PHARMACEUTICALS, INC.RXRX

Director

Transactions

Award
Class A Common Stock
2025-10-01+2,941→ 138,758 total

Footnotes (1)

[F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

Documents

1 file

4
wk-form4_1759523248.xmlPrimary
FORM 4

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1

filerCIK 0001852075

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 4:27 PM ET
Size: 4.8 KB

View on SEC.gov